172P Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive locally advanced/metastatic gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJA): Primary efficacy and safety from the phase II single-arm DESTINY-Gastric06 (DG06) trial

Lin Shen, Pei Chen, Jun Lü, Yueping Wan, Yang Zheng, Fayin Ye, Jingcheng Yang, Y. Liu, Hongming Pan, Hui Chen, Meili Sun, Qiang Fan, Y. Yuan, Ken Chen, Ziyong Sun, He Tian, Xianjiang Ye, Zhi Peng